Psyched Clinical Trials: Australian Univ. Pursues MDMA, MEAI Compound About To Set Off

Monash University Engages LaNeo MDMA Australian Monash University’s psychedelics research lab has contracted MDXX-class molecules developer PharmAla Biotech to manufacture and supply its clinical-grade MDMA LaNeo for an upcoming Phase 2 clinical study. Delivery is set for this summer. This is PharmAla’s fourth MDMA supply for a major clinical trial in Australia. Notably, PharmAla is […]